「retina」の検索結果
22件：6～10件目を表示
-
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eyeP3（China） SJP-0008Central Retinal Artery Occlusion (CRAO)P3（Japan） SJP-0170GlaucomaP3（Japan） SJP-0154Dry eyeP2（Japan） SJP-0049...
https://www.senju.co.jp/english/rd/pipeline.html -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
70 Japan Completed jRCT2031240149 Dry Eye Disease 2 SJP-0154 Japan Completed jRCT2031240009 Central Retinal Artery Occlusion 3 SJP-0008 Japan Completed jRCT2011230042 Primary Open Angle Glaucoma or Oc...
http://www.senju.co.jp/english/rd/trial.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
ty, Utah, United States of America Protective effects of chemerin from iPSC-derived Müller cells on retinal ganglion cell Momoko Kobayashi, Yayoi Kishimoto, Mitsuyoshi Azuma, Chiho Fukiage, Noriyuki A...
http://www.senju.co.jp/english/rd/society/ -
お知らせ | 千寿製薬株式会社
SJP-0132（PDF） July 8, 2024 Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion（PDF） May 9, 2024 Senju announces initiation of Phase III Clinical Trials in...
http://www.senju.co.jp/english/news/ -
学会发表 | 研究与开发 | 千寿制药株式会社
ty, Utah, United States of America Protective effects of chemerin from iPSC-derived Müller cells on retinal ganglion cell Momoko Kobayashi, Yayoi Kishimoto, Mitsuyoshi Azuma, Chiho Fukiage, Noriyuki A...
http://www.senju.co.jp/chinese/rd/society/